| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 04/20/2005 | EP1523549A2 Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury |
| 04/20/2005 | EP1523541A1 A process for decreasing environmental pollutants in an oil or a fat, a volatile environmental pollutants decreasing working fluid, a health supplement, and an animal feed product |
| 04/20/2005 | EP1523320A1 Megasphaera elsdenii strain and its uses |
| 04/20/2005 | EP1523319A1 Method for sustaining direct cell delivery |
| 04/20/2005 | EP1523311A1 Calcium lactate and whey permeate for lowering the triglyceride level |
| 04/20/2005 | EP1401456A4 Method fron determining the efficacy of reverse cholesterol transport enhancing agents |
| 04/20/2005 | EP1002120B1 Chimeric adenoviral vectors |
| 04/20/2005 | EP0787200B1 Improved adenovirus and methods of use thereof |
| 04/20/2005 | EP0775213B1 Adenovirus comprising a gene coding for glutathion peroxidase |
| 04/20/2005 | EP0700430B1 Methods for selectively stimulating proliferation of t cells |
| 04/20/2005 | CN1608135A Methods and compositions for inducing tumor-specific cytotoxicity |
| 04/20/2005 | CN1607942A Pharmaceutical compositions in particulate form |
| 04/20/2005 | CN1607941A Pharmaceutical compositions in particulate form |
| 04/20/2005 | CN1607254A Process for preparing bio- red selenium |
| 04/20/2005 | CN1606985A Beewax essence millimicrosphere preparation and its uses in medicine |
| 04/20/2005 | CN1606984A Method for making refined Maifan stone |
| 04/20/2005 | CN1606929A Highly active multifunctional products series of earthworm and its production method |
| 04/20/2005 | CN1197956C Lactobacillus helvetius producing antihypertensive di- and tripeptides |
| 04/20/2005 | CN1197872C Polypeptide with alpha-galactosidase activity and its coding nucleic acid |
| 04/20/2005 | CN1197619C Biological therapy adjuvant originated from animal Chinese medicine |
| 04/20/2005 | CN1197615C Antineoplastic medicine and its preparation process |
| 04/20/2005 | CN1197613C Medicine for treating neck, shoulder, waist and leg pains |
| 04/20/2005 | CN1197611C Medicine for treating choleithiasis and preparing method thereof |
| 04/20/2005 | CN1197610C Chinese medicine preparation against cold |
| 04/20/2005 | CN1197609C Chinese medicine for treating impotence and its preparation method |
| 04/20/2005 | CN1197608C Medicine for treating esophageal cancer and gastric cancer and its preparation method |
| 04/20/2005 | CN1197606C Drug and preparation method for improvement of organism immunity |
| 04/20/2005 | CN1197602C External medicine for treating sterility and women's diseases and its prepn |
| 04/20/2005 | CN1197600C Medicine for curing haemorrhoids |
| 04/20/2005 | CN1197598C Biological wall breaking technology for rape melissa powder |
| 04/20/2005 | CN1197596C Massaging cream for relaxing muscles and tendons and its preparation method |
| 04/20/2005 | CN1197595C Chinese medicine preparation for broad-spectrum inflammation relieving, disinfecting, erosion prevention and muscle growing |
| 04/20/2005 | CN1197594C Chinese traditional medicinal pill for treating cardiovascular and cerebrovascular disease |
| 04/20/2005 | CN1197592C Pure traditional Chinese medicinal preparation for treating child's epilepsy disease and its preparing method |
| 04/20/2005 | CN1197591C Use of acellular short corynebacteria preparation in preparation of medicine for treating tuberculosis |
| 04/20/2005 | CN1197590C Bee product composition for treating diabetes and its preparation method |
| 04/20/2005 | CN1197589C Sore ulcer treating ointment and its prepn. |
| 04/20/2005 | CN1197564C Application of fur seal oil in preparation of medicine for treating lipometabolism disorder |
| 04/20/2005 | CN1197554C Solid lipid formulations |
| 04/19/2005 | US6881575 Using fluorescent activated cell sorting to separate and isolate cells comprising mutations in cell proliferation; anticarcinogenic agents; antiproliferative agents |
| 04/19/2005 | US6881408 Removal of complement factors and lipopolysaccharides (LPS) and, if need be, further sepsis mediators such as TNF and interleukins from body fluids, methods for their production and their use. |
| 04/19/2005 | CA2265252C Angiogenic factor and use thereof in treating cardiovascular disease |
| 04/14/2005 | WO2005033302A1 Method of preparing hair papilla cell preparation, composition and method for regenerating hair follicle and animal having regenerated hair follicle |
| 04/14/2005 | WO2005033301A1 Cell activation method and cell production method and medicinal composition using the same |
| 04/14/2005 | WO2005033299A1 Method of repairing primate mammalian tissue |
| 04/14/2005 | WO2005033297A1 Compositions, methods and kits relating to reprogramming adult differentiated cells and production of embryonic stem cell-like cells |
| 04/14/2005 | WO2005033292A2 Methods of establishing intercellular communication in an endothelial cell layer and uses thereof |
| 04/14/2005 | WO2005033126A1 Cell surface marker |
| 04/14/2005 | WO2005032618A1 Blood pack for leukocyte banking |
| 04/14/2005 | WO2005032591A1 Compositions and methods for augmenting kidney function |
| 04/14/2005 | WO2005032567A2 Method to treat the side effects associated with non steroidal anti-inflammatory drugs using microorganisms of the genus bifidobacterium |
| 04/14/2005 | WO2005032566A1 Method of replenishing cells damaged by treatment for cancer |
| 04/14/2005 | WO2005032565A1 Blood co-processing for contingent autologous leukocyte transplantation |
| 04/14/2005 | WO2005032564A1 Cell bank for contingent autologous leukocyte transplantation |
| 04/14/2005 | WO2005032462A2 Glucocerebroside treatment of disease |
| 04/14/2005 | WO2005002602A3 Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus and insulin resistance |
| 04/14/2005 | WO2005000325A3 Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus |
| 04/14/2005 | WO2004113515A3 Tissue modeling in embryonic stem (es) cell system |
| 04/14/2005 | WO2004011485A3 Stabilized bioactive peptides and methods of identification, synthesis, and use |
| 04/14/2005 | WO2003083069A3 Activation of tumor-reactive lymphocytes via antibodies or genes recognizing cd3 or 4-1bb |
| 04/14/2005 | US20050080069 comprises Potassium tetrachloroplatinate and lignohumic acid ammonium salts; nontoxic |
| 04/14/2005 | US20050080051 for the treatment of hyperlipidemia and blood coagulation disorders; phosphatidylinositol, phosphatidylserine, phosphatidylglycerol, or phosphatidic acid; dyslipidemia and atherosclerosis |
| 04/14/2005 | US20050080009 Storage-stable, liquid fibrinogen formulation |
| 04/14/2005 | US20050079616 Method of transducing ES cells |
| 04/14/2005 | US20050079609 Methods and devices for the long-term culture of hematopoietic progenitor cells |
| 04/14/2005 | US20050079608 Lineage committed stem cells selected for telomerase promoter activity |
| 04/14/2005 | US20050079606 Pluripotent stem cells originating in skeletal muscle intestinal tissue |
| 04/14/2005 | US20050079597 Antimicrobial composition |
| 04/14/2005 | US20050079581 Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor |
| 04/14/2005 | US20050079578 Generating transgenic cell which express keratinocyte growth factor-2 (KGF-2) for use ase tool in treatment of ulcers and inflammatory bowel disease |
| 04/14/2005 | US20050079572 Expression vector comprising nuclelotide sequences coding brain acid soluble protein 1 (BASP1) for use in prevention and treatment of infection, cell proliferative, inflammatory and autoimmune disorders; gene therapy; immunotherapeutics |
| 04/14/2005 | US20050079560 Detection and treatment of cancers of the colon |
| 04/14/2005 | US20050079495 Modified membrane protein comprising proteolytic and is absent for g-protein coupling for use as tool in diagnosis, prevention and treatment of pain, arthritis, asthma, psychological and gastrointestinal disorders |
| 04/14/2005 | US20050079480 Method and apparatus for reducing pathogens in a biological sample |
| 04/14/2005 | US20050079166 Drug delivery; heating substrate ; solid fuels; exothermic metal oxidation ; high speed vaporization of drug |
| 04/14/2005 | US20050079162 Method for improving oxygen transport by stored red blood cells |
| 04/14/2005 | US20050079161 Transluminal application of adult stem cells for body organ tissue repair |
| 04/14/2005 | US20050079159 Autologous tissue for connecting structures; regeneration of tissue; cell differentiation of pluripotent cells |
| 04/14/2005 | US20050079158 Construct of anti-cancer recombinant adenovirus, method for preparing the same and use thereof |
| 04/14/2005 | US20050079157 Combination bacteriolytic therapy for the treatment of tumors |
| 04/14/2005 | CA2580712A1 Blood pack for leukocyte banking |
| 04/14/2005 | CA2545248A1 Methods for altering hematopoietic progenitor cell adhesion, differentiation, and migration |
| 04/14/2005 | CA2540672A1 Educated nkt cells and their uses in the treatment of immune-related disorders |
| 04/14/2005 | CA2540666A1 Glucocerebroside treatment of disease |
| 04/14/2005 | CA2540535A1 Blood co-processing for contingent autologous leukocyte transplantation |
| 04/14/2005 | CA2540467A1 Compositions and methods for augmenting kidney function |
| 04/14/2005 | CA2537769A1 Method to treat the side effects associated with non steroidal anti-inflammatory drugs using microorganisms of the genus bifidobacterium |
| 04/14/2005 | CA2537318A1 Method of repairing primate mammalian tissue |
| 04/14/2005 | CA2537314A1 Method of replenishing cells damaged by treatment for cancer |
| 04/14/2005 | CA2527700A1 Stem cells for clinical and commercial uses |
| 04/14/2005 | CA2527617A1 Benzo-(4,5)-thieno-(2,3d)-pyrimidin-4-ones and their use in the treatment or prevention of a steroid hormone dependent disease or disorder |
| 04/13/2005 | EP1522591A2 Transgenically produced non-secreted proteins |
| 04/13/2005 | EP1522307A1 Dialyzed leukocyte extract for the treatment of infectious diseases in animals |
| 04/13/2005 | EP1521839A1 Methods of making viral particles having a modified cell binding activity and uses thereof |
| 04/13/2005 | EP1521593A2 Transdermal botulinum toxin compositions |
| 04/13/2005 | EP1390471A4 Method for autologous transplantation |
| 04/13/2005 | EP1339356B1 Tissue-engineered vascular structures |
| 04/13/2005 | EP1090105B1 Non-embryonic ependymal neural stem cells and method for their isolation |
| 04/13/2005 | EP0956052B1 Chimeric retrovirus/adenovirus system |
| 04/13/2005 | CN1606614A Dermal replacement prepared from mesenchymal cells of hair follicle |